News

Analytik Jena Announces Preliminary Results of Financial Year 2011/2012

12.11.2012 | Nouveautés
  • Forecast exceeded with sales of EUR 94.0 m
  • Operating profit increased by 21.7 %
  • Organic growth with strong business in Asia

Jena (Germany), November 12, 2012 — Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) posted a marked growth in sales and earnings for financial year 2011/2012. The total sales of the Group increased by 8.9 % to EUR 94.0 m (previous year: EUR 86.3 m). Thereby, the Company exceeded its forecast in the reporting year and achieved another sales record.

The earnings before interest and taxes (EBIT) amounted to EUR 6.1 m (previous year: EUR 5.0 m) at the end of the financial year. Thereby, Analytik Jena achieved a double-digit operating earnings growth of 21.7 %. The EBIT margin has increased by seven percentage points from 5.8 % in the previous year to 6.5 %. For earnings before taxes and earnings per share the Company also expects a marked increase in comparison to the previous year.

"The financial year 2011/2012 was a very successful year for Analytik Jena. The results are expedited particularly by a strong business in Asia in our core business unit Analytical Instrumentation. We are very satisfied with a new record level of sales as well as a significant increase in earnings considering also the difficult global economic conditions and the declining development in the European area", said Klaus Berka, CEO of Analytik Jena AG.

Growth rates in sales and earnings have been achieved in the course of a very good development of the Company on the global markets and particularly by an excellent export business in the Asian region. In this region the Company achieved an increase of sales by 30.8 %. The Group benefited from a growing market penetration in the whole Asian region as well as the X-ray fluorescence equipment business in Japan, which has had an excellent start. These products which are based on a strategic cooperation with the Japanese company Techno X, will initially only be sold on the Japanese market but shall, in the medium term, also be offered worldwide. In contrast to Asia, sales on the European markets (excl. Germany) declined. Particularly due to decreasing sales figures in Southern Europe 14.5 % lower sales were achieved in this region in the financial year in comparison to the previous year.

The Company expects to be able to continue its overall positive business development in the new financial year 2012/2013.

The figures given in the announcement are preliminary figures. The final results for the 2011/2012 financial year (as at September 30) will be announced by the Group on December 18, 2012.


Contact

Hanna Engelhardt
Media Relations Life Science
+49 (0) 36 41  77-73 55press@laboservices.tn

The newsletter of Analytik Jena frequently keeps you posted about:

Sign up here